Biotech Xeltis announces FDA Breakthrough Device Designation for aXessTM and first patient treated in US pivotal trial November 14, 2024
Biotech Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates November 13, 2024
Biotech Innocan to Direct Full Focus on Following Positive FDA Engagement and Significant Potential Market Demand November 12, 2024
Biotech Nordic Bioscience receives Letter of Support from the FDA for the CPa9-HNE biomarker in inflammatory bowel diseases November 11, 2024
Biotech Sapience Therapeutics Presents Clinical Data on Two Lead Programs, Including ST101 Oral Presentation, at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting November 10, 2024
Biotech WILLOW BIOSCIENCES ANNOUNCES NEW PARTNERSHIP WITH A GLOBAL INGREDIENT MANUFACTURER TO ADVANCE DEVELOPMENT OF A HIGH VALUE INGREDIENT FROM ITS PORTFOLIO November 8, 2024
Biotech Naitive® and Parvizi Surgical Innovation Partner to Advance Osteoporosis Detection November 7, 2024
Biotech Leads Biolabs Receives Orphan Drug Designation from the US FDA for LBL-034, a Uniquely Designed, Highly Differentiated Anti-GPRC5D/CD3 Bispecific Antibody, for the Treatment of Multiple Myeloma November 6, 2024
Search
Biotech
November 15, 2024
November 14, 2024
November 13, 2024
November 12, 2024
November 11, 2024
November 10, 2024
November 9, 2024
November 8, 2024
November 7, 2024
November 6, 2024
